29623-29-8 Usage
Uses
Used in Pharmaceutical Applications:
13-Oxo-9E,11E-octadecadienoic acid is used as a therapeutic agent for its anti-inflammatory and anti-cancer properties. It is being studied for its potential to modulate inflammatory responses and inhibit the growth of cancer cells, making it a candidate for the development of new treatments in these areas.
Used in Research and Development:
In the field of scientific research, 13-Oxo-9E,11E-octadecadienoic acid is used as a subject of study to further understand its role in human biochemistry. Researchers are investigating its interactions with various biological systems and its potential applications in medicine, which could lead to the discovery of new therapeutic strategies.
Used in Nutritional Supplements:
13-Oxo-9E,11E-octadecadienoic acid may be used as an ingredient in nutritional supplements, particularly those aimed at supporting anti-inflammatory and anti-cancer health benefits. Its presence in these products is based on the compound's known properties, although the effectiveness and safety of such supplements are still under evaluation.
Check Digit Verification of cas no
The CAS Registry Mumber 29623-29-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,9,6,2 and 3 respectively; the second part has 2 digits, 2 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 29623-29:
(7*2)+(6*9)+(5*6)+(4*2)+(3*3)+(2*2)+(1*9)=128
128 % 10 = 8
So 29623-29-8 is a valid CAS Registry Number.
29623-29-8Relevant academic research and scientific papers
Easy access to various natural keto polyunsaturated fatty acids and their corresponding racemic alcohols
Iacazio, Gilles
, p. 115 - 121 (2007/10/03)
Various optically active hydroxy derivatives of polyunsaturated fatty acids were easily oxidised to their corresponding keto derivatives using Dess-Martin periodinane. The reaction was run on the millimolar scale with good yields and without appreciable isomerisation of the surrounding double bonds. Reduction of these keto compounds to yield back the starting alcohols, but now as racemic mixtures, was also conducted using CeCl3-NaBH 4, once again without noticeable modification of the stereochemistry of the double bonds. These reactions proved the usefulness of the chemoenzymatic access to oxylipins through the use of lipoxygenases with various regiospecificity, combined with chemical transformations of the formed hydro(pero)xides.
